Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer

N. Sunaga, K. Kaira, H. Imai, K. Shimizu, T. Nakano, D. S. Shames, L. Girard, J. Soh, M. Sato, Y. Iwasaki, T. Ishizuka, A. F. Gazdar, J. D. Minna, M. Mori

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences